Allotera Therapeutics logo

Allotera Therapeutics Employee Directory

Biotechnology ResearchMissouri, United States11-50 Employees

Wugen, Inc. is a clinical-stage biotechnology company headquartered at 4260 Forest Park Avenue Suite 100, St. Louis, Missouri 63108, United States, focused on developing next-generation allogeneic CAR-T cell therapies for cancer. It operates in the biotechnology research industry and has a workforce of approximately 51 to 200 employees. The company has a proprietary gene-editing platform designed to overcome key limitations of first-generation cell therapies, enabling scalable off-the-shelf treatments with cost-of-goods margins akin to biologics. Its lead program, WU-CART-007, targets CD7 and has demonstrated efficacy in T-ALL/T-LBL, with potential to be the first approved allogeneic CAR-T therapy for T-cell malignancies. Information about the company is available on its website at https://wugen.com.

Find Allotera Therapeutics employees' phone numbers or email addresses

Allotera Therapeutics Global Highlights

Location
Employees

North America
56

Minus sign iconPlus sign icon
  • United States Of America
    56

Europe
4

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Italy
    1
  • Georgia
    1

Allotera Therapeutics's Leadership

  • Chief Technology Officer at Allotera Therapeutics
    J. F.
    Chief Technology Officer
  • Founder + Creative Director at Allotera Therapeutics
    C. S.
    Founder + Creative Director
  • Co-Founder at Allotera Therapeutics
    T. F.
    Co-Founder
  • Executive Director, Head Of Biostatistics, Data Management And Sas Programming at Allotera Therapeutics
    T. W.
    Executive Director, Head Of Biostatistics, Data Management And Sas Programming
  • Board Director | Lead Investor at Allotera Therapeutics
    B. H.
    Board Director | Lead Investor
  • Laboratory Manager at Allotera Therapeutics
    A. P.
    Laboratory Manager
  • Principal Scientist at Allotera Therapeutics
    J. H.
    Principal Scientist
  • Scientist at Allotera Therapeutics
    R. W.
    Scientist

Allotera Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Legal
  • Consultant
  • Entrepreneurship
  • Other

Contact profiles from Allotera Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Technology Officer at Allotera Therapeutics
    J. F.
    Chief Technology Officer
    United Kingdom, England
    Sep 02, 2026
  • Founder + Creative Director at Allotera Therapeutics
    C. S.
    Founder + Creative Director
    Oct 18, 2024
  • Co-Founder at Allotera Therapeutics
    T. F.
    Co-Founder
    Oct 22, 2024
  • Executive Director, Head Of Biostatistics, Data Management And Sas Programming at Allotera Therapeutics
    T. W.
    Executive Director, Head Of Biostatistics, Data Management And Sas Programming
    Aug 26, 2026
  • Board Director | Lead Investor at Allotera Therapeutics
    B. H.
    Board Director | Lead Investor
    Hong Kong, Central and Western
    Jul 10, 2026
  • Laboratory Manager at Allotera Therapeutics
    A. P.
    Laboratory Manager
    Aug 29, 2024
  • Principal Scientist at Allotera Therapeutics
    J. H.
    Principal Scientist
    Oct 23, 2024
  • Scientist at Allotera Therapeutics
    R. W.
    Scientist
    Jul 10, 2026
  • Sales Clerk at Allotera Therapeutics
    A. M.
    Sales Clerk
    Oct 21, 2024

Frequently Asked Questions

What is Allotera Therapeutics known for?

Minus sign iconPlus sign icon
Allotera Therapeutics was founded in 2018 and operates in the Biotechnology Research industry. Explore Allotera Therapeutics's company overview page for more information.

What is Allotera Therapeutics's most common email format?

Minus sign iconPlus sign icon
Allotera Therapeutics employees' email format typically follows the pattern of FLast@wugen.com. Trying to find reliable and up-to-date employee contact data? Find more Allotera Therapeutics email formats with LeadIQ.

How many employees does Allotera Therapeutics have currently?

Minus sign iconPlus sign icon
Allotera Therapeutics has approximately 44 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Allotera Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Allotera Therapeutics's key employees include:

  • Chief Technology Officer: J. F.
  • Founder + Creative Director: C. S.
  • Co-Founder: T. F.
  • Executive Director, Head Of Biostatistics, Data Management And Sas Programming: T. W.
  • Board Director | Lead Investor: B. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.